In a 52-week clinical trial, those taking Semaglutide lost an average of 16.1% of their body weight, while those taking placebo lost an average of 4.7% of their body weight
Weight loss medications can also act as appetite suppressants, reduce cravings, and/or block the absorption of dietary fat
By targeting three complementary hormone receptors simultaneously, these investigational therapies aim to improve multiple aspects of metabolic health rather than focusing solely on glucose control
once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
When you take a drug, it needs to be absorbed into your bloodstream to be effective
The clinic is a unique practice dedicated to caring for menopausal patients